Coloplast Financials
| CLPBY Stock | USD 10.62 0.01 0.09% |
Coloplast |
Understanding current and past Coloplast Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Coloplast's financial statements are interrelated, with each one affecting the others. For example, an increase in Coloplast's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Coloplast's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Coloplast A. Check Coloplast's Beneish M Score to see the likelihood of Coloplast's management manipulating its earnings.
Coloplast Stock Summary
Coloplast competes with Straumann Holding, Hoya Corp, EssilorLuxottica, Essilor International, and Sysmex Corp. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US19624Y2000 |
| Business Address | Holtedam 1-3, Humlebk, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.coloplast.com |
| Phone | 45 49 11 11 11 |
| Currency | USD - US Dollar |
Coloplast Key Financial Ratios
Coloplast's financial ratios allow both analysts and investors to convert raw data from Coloplast's financial statements into concise, actionable information that can be used to evaluate the performance of Coloplast over time and compare it to other companies across industries.Coloplast Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Coloplast's current stock value. Our valuation model uses many indicators to compare Coloplast value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Coloplast competition to find correlations between indicators driving Coloplast's intrinsic value. More Info.Coloplast A is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Coloplast A is roughly 4.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Coloplast by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Coloplast's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Coloplast A Systematic Risk
Coloplast's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Coloplast volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Coloplast A correlated with the market. If Beta is less than 0 Coloplast generally moves in the opposite direction as compared to the market. If Coloplast Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Coloplast A is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Coloplast is generally in the same direction as the market. If Beta > 1 Coloplast moves generally in the same direction as, but more than the movement of the benchmark.
Coloplast March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Coloplast help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Coloplast A. We use our internally-developed statistical techniques to arrive at the intrinsic value of Coloplast A based on widely used predictive technical indicators. In general, we focus on analyzing Coloplast Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Coloplast's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 7.54 | |||
| Value At Risk | (2.33) | |||
| Potential Upside | 1.93 |
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.